Table 3 of Campos-Mollo, Mol Vis 2009; 15:417-431.


Table 3. Clinical features of patients with either CYP1B1 mutations or no detected mutations.

Family
(Patient
number)


CYP1B1
mutation

Gender/
laterality
Age at
diagnosis
(months)
aIOP
(mm Hg)
at diagnosis
(OD/OS)
Initial
surgery
(OD/OS)
Number of
glaucoma surgical
interventions
(OD/OS)
Age at
last
follow up
(years)
Visual Acuity
(Snellen chart)
(OD/OS)
Corneal
status
(OD/OS)
Cup/disc
ratio
(OD/OS)
PCG 2 (II:1) p.G61E/p.T404fsX30 F/B 1 28/40 G/G 4/2 31 0.8/HM C/C ND/ND
PCG 21 (III:1) p.R390S/p.A179fsX18s M/B 2 ND/ND G/G >1/>1 30 A/1 A/C A/0.4
PCG 5 (III:1) p.R355fsX69/p.G61E M/B 24 28/26 G/G >1/>1 26 1/1 C/C 0.3/0.3
PCG 3 (III:3) p.P52L/+ M/B ND ND/ND G/G 2/2 15 0.3/LP C/MSS 0.3/0.8
PCG 4 (III:2) p.Y81N/+ M/U (OS) 23.5 16/30 -/CTT 0/1 6 0.9/1 C/C 0.2/0.2
PCG 1 (IV:2) p.R355fsX69/p.F261L F/U (OD) 0 23/12 -/CTT 1/0 3 1/1 C/C 0.2/0.2
PCG 25 (II:1) p.R469W/p.T404fsX30 M/B 0 25/37 G/G 2/1 30 1/0.7 ND/ND ND/ND
PCG 25 (II:2) p.R469W/p.T404fsX30 F/B 0 ND/ND ND/ND ND/ND 32 LP/LP ND/ND ND/ND
PCG 27 p.T404fsX30/p.R355fsX69 M/B 2 27/29 T/T 2/2 4 0.25/0.15 C/MSS 0.8/UA
PCG 28 p.E173X/p.P400S M/B 0 32/30 T/T 3b/3b 8 0.3/0.3 C/C 0.8/0.9
PCG 29 p.E262X/p.P513_K514del F/B 2 18/24 T/T 4b/3b 6 0.9/Ac C/C 0.6/UA
PCG 32 p.T404fsX30/p.P513_K514del M/B 1 38/39 G/G 4/2 29 ND/ND CCE/C ND/ND
PCG 34 p.W341X/p.T404fsX30 M/B 0 20/20 G/G 5/2 38 0.5/0.5 C/C ND/ND
PCG 45 p.P437L/p.A106D F/B 36 16/32 T/T 2b/2b ND 0.4/0.6 ND/ND ND/ND
PCG 26 - F/B 0 35/35 ND/ND 2/2 ND ND/ND ND/ND ND/ND
PCG 10 - M/B 9 30/30 G/G 3/2 30 0.05/LP CCE/CCE UA/UA
PCG 22 - F/U (OS) 18 ND/ND -/Tt 0/1 30 1/LP C/CCE 0.3/UA
PCG 11 - F/U (OS) ND ND/ND -/G 0/1 27 1/1 C/C 0.3/0.3
PCG 9 - M/B 0.5 ND/ND CTT/CTT 3/3 24 Ad/Ae d/e d/e
PCG 15 - M/B 4 20/20 Tt/Tt 1/1 24 1/1 C/C 0.2/0.2
PCG 6 - M/U (OS) 15 12/20 -/Tt 0/1 24 1/1 C/C 0.2/0.2
PCG 13 - M/U (OS) 4 ND/ND -/G 0/2 22 1/Ae C/e 0.3/e
PCG 8 - M/B 2.5 22/22 CTT/CTT 1/1 17 1/1 C/C 0.2/0.2
PCG 14 - M/B 1 22/22 CTT/CTT 1/1 16 1/0.7 C/MSS 0.3/0.4
PCG 7 - M/B 5.5 20/20 CTT/CTT 2/1 12 0.3/LP C/CCE UA/UA
PCG 12 - M/B 15 22/24 CTT/CTT 1/1 12 0.8/0.8 MSS/MSS 0.3/0.7
PCG 16 - M/U (OD) 0.6 23/10 CTT/- 1/0 11 0.5/1 C/C 0.2/0.2
PCG 17 - M/U (OS) 6 10/20
-/CTT 0/1 5 1/0.05 C/MSS 0.3/0.3
PCG 18 - M/U (OD) 1 17/10 CTT/- 1/0 5 0.5/1 C/C 0.2/0.2
PCG 19 - F/B 28.5 20/20 CTT/CTT 1/1 3 ND/ND C/C ND/ND
PCG 25b - M/B ND ND/ND ND/ND ND/ND 29 A/A ND/ND ND/ND
PCG 30 - M/B 0 23/28 G/G 3/2 8 0.7/0.5 C/C 0.4/0.4
PCG 33 - M/B 3 26/35 G/G 4/4 27 LP/LP KB/PB ND/ND
PCG 35 - F/B 3 20/20 G/G 3/3 28 0.5/0.5 C/C ND/ND
PCG 36 - M/B 4 15/15 G/G 3/1 2 ND/ND C/C ND/ND
PCG 41 - F/B 10 40/40 G/G 3/5 ND ND/ND ND/ND 0.9/0.9
PCG 42 - M/B 4 38/30 G/T 3/2 ND ND/ND ND/ND 0.8/0.8
PCG 43 - M/B 7 22/30 ND/ND ND/ND ND ND/ND ND/ND 0.2/0.3
PCG 44 - M/B 48f 13/24 G/G >1b/>1b ND 0.5/0.4 d/CCE UA/UA